Tag Archive for: Series

Double invest by Forbion in quite different topics: in-vivo celltherapy and neurological disorders. (courtesey Capstan Inc.; Engrail Thx)

Forbion, the European life sciences venture capital firm from The Netherlands, announced its participation in oversubscribed Series B financing in Capstan Therapeutics Inc. and Engrail Therapeutics. Both companies are located in San Diego, USA.

Curve Therapeutics' CSO and co-founder Ali Tavassoli. © University of Southampton

Intracellular cancer target screening specialist Curve Therapeutics Ltd has closed a £40.5m financing led by Pfizer Ventures to advance its preclinical pipeline of small cyclic petides.

© MIP Discovery

MIP Discovery Ltd has closed a £7M Series A financing to drive commercialisation of its synthetic affinity reagents in cell and gene therapy.